US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 22, 2013 (13 years ago)

Tobramycin Opth Soln 14mg/ml

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.

What was recalled

Tobramycin Opth Soln 14mg/ml, 7ml Opthalmic Soln, 10 day expiration,

Recalling firm
Nora Apothecary and Alternative Therapies, Inc.
Origin
IN, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-470-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tobramycin recalls

See all
Class II · Moderate risk Terminated

Tobramycin for Injection

Reason Failed Stability Specification: Water determination was found not complying with specification.

Eugia US LLC NDC 55150-470-06 D-0385-2024
Class III · Low risk Ongoing

Tobramycin Opthalmic Solution USP

Reason Failed Impurities/Degradation Specifications

Alembic Pharmaceuticals, INC. NDC 62332-518-05 D-1086-2023
Class II · Moderate risk Ongoing

Tobramycin Ophthalmic Solution

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0851-2023
Class II · Moderate risk Ongoing

Tobramycin Inhalation Solution USP

Reason CGMP Deviations: Firm went out of business and could no longer continue stability studies.

Akorn, Inc. D-0850-2023
Class II · Moderate risk Terminated

Tobramycin 660mg in Ns 66ml

Reason Lack of sterility assurance

Sentara Infusion Services D-0317-2023